![](/img/cover-not-exists.png)
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
Saloura, Vassiliki, Cohen, Ezra E. W., Licitra, Lisa, Billan, Salem, Dinis, Jose, Lisby, Steen, Gauler, Thomas C.Volume:
73
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2459-z
Date:
June, 2014
File:
PDF, 1.42 MB
english, 2014